We are pleased to announce our next meeting at the new Las Vegas HEALS location in Summerlin at the Roseman University of Health Sciences, One Breakthrough Way, Las Vegas, NV 89135. Please join us Tuesday October 30th at 11:30 AM, as we engage in identifying challenges and proposed action items for addressing the issues that keep Human Resource Teams and leaders in the Healthcare community up at night.
We have included a light lunch to help us fit this important time into your busy calendars. We also plan to identify a day and time for a recurring monthly lunch meeting going forward.
We have a special guest speaker in John Packham, PhD (Associate Dean, Office of Statewide Initiatives with University of Nevada, Reno School of Medicine Reno), so we know you will not want to miss this opportunity. Please access the following links to preview Dr. Packham’s reports …
The Clark County Medical Society (CCMS) will host two Stop the Bleed training courses in recognition of the first anniversary of the 1 October mass shooting on Monday, September 24.
The event, which will take place at the Clark County Medical Society offices at 2590 E. Russell Road, will consist of a Basic Stop the Bleed training for the general public as well as a Stop the Bleed Instructor course for medical students and physicians in order to help grow the number of course instructors in our area.
Stop the Bleed training empowers the public to help in life-threatening situations by teaching basic bleeding control techniques. According to their website, www.bleedingcontrol.org, Nevada’s current 152 instructors have already trained over 3,000 people.
“In the event of a tragedy like 1 October, this kind of training can make the difference between a patient making it to the hospital or not,” said CCMS Treasurer and trauma surgeon Dr. Deborah Kuhls. “We’ve already put thousands of people through this course, but to grow that number we need more instructors.”
Physician members of the Clark County Medical Society saw firsthand the incredible response of the general public to the shooting as civilians transported hundreds of wounded to local medical centers in their personal vehicles. By offering the Stop the Bleed Instructor course, the medical society aims to expand the number of people who receive this vital training by creating a larger base of qualified teachers.
“We are really excited to offer the instructor course to our physicians and medical students,” Dr. Kuhls said. “The medical students alone nearly filled up the entire instructor course as soon as we opened registration, so we know there is a huge demand for this kind of programming.”
For more information about the Clark County Medical Society, or to register for the Stop the Bleed course, go to www.clarkcountymedical.org/stopthebleed.
Comprehensive analysis reiterates drug development remains direly slow, but new trends include emphasis on disease-modifying therapies and an increase in the use of biomarkers to support diagnosis
Cleveland Clinic’s third annual analysis of Alzheimer’s disease drug development reveals that drug development continues to be disappointingly slow. Researchers, however, are learning more about evolving targets in the pipeline, including a movement toward disease prevention and an emphasis in disease-modifying therapies.
The paper, Alzheimer’s disease drug development: pipeline 2018, is based on the federal website ClinicalTrials.Gov and appears as a feature article in the journal Alzheimer’s & Dementia: Translational Research & Clinical Trials Interventions (TRCI).
While the Alzheimer’s drug development pipeline is slightly larger in 2018 than 2017, researchers note that a disease-modifying therapy that will prevent or delay the onset or slow progression of the disease is urgently needed. Even a modest, one-year delay in onset by 2020 would result in there being 9.2 million fewer cases of Alzheimer’s by 2050. Of the 112 agents in the pipeline, 63 percent are disease-modifying therapies. Moreover, there is a shift to treat those with milder forms of Alzheimer’s as there are more trials in preclinical populations, including cognitively normal individuals at high risk for developing the disease (due to their genetic profile or having evidence of amyloid build up from either brain scans or cerebrospinal fluid testing).
“Cleveland Clinic continues to be a leader in assessing the evolution of new therapies for Alzheimer’s and we believe it’s crucial to drive conversation about our annual findings in effort to foster collaboration and bring public awareness to the need for acceleration of drug development,” said Aaron Ritter, M.D., director of the clinical trials program of Cleveland Clinic Lou Ruvo Center for Brain Health. “Our annual pipeline paper clearly illustrates that there just aren’t enough drugs in the Alzheimer’s disease development pipeline. We can increase our chances of finding life-changing treatments for Alzheimer’s disease by testing more drugs and doing it quickly and efficiently.”
Using a search of ClinicalTrials.Gov, Dr. Ritter, along with fellow authors Jeffrey Cummings, M.D., ScD, director emeritus of Cleveland Clinic Lou Ruvo Center for Brain Health, Kate Zhong, M.D., Chief Strategy Officer of Global Alzheimer’s Platform and Garam Lee, Pharm.D., clinical research pharmacist at Cleveland Clinic Lou Ruvo Center for Brain Health, examined all clinical trials from 2017 to 2018 to reveal the need for greater use of biomarkers, and that while there is a shift in efforts toward preventative measures, the few number of agents targeting moderate to advanced stages of Alzheimer’s and the small number of therapies entering Phase 1 is concerning. In addition, researchers found that infused antibodies are a major type of evolving therapy that bode potentially exciting results.
For example, the recent results from aducanumab and BAN2401 trials are particularly encouraging as the antibody protein is thought to decrease the amyloid plaques and possibly slow neurodegeneration and reduce disease progression.
Furthermore, immediate challenges of drug development include the lack of surrogate biomarkers. Biomarkers are not only important for the development of disease-modifying therapies, but also symptomatic drugs and are currently used to improve diagnostic accuracy. However, review of the pipeline shows that a surprisingly low percentage of disease-modifying therapy trials requires diagnostic biomarkers for entry or secondary outcomes, concluding the development and use of biomarkers for Alzheimer’s clinical trials remains an unmet goal.
Though improvements are needed, proactive steps toward clinical trial efficiency are currently underway, including the widespread use of online registries to help recruit qualified trial participants. Researchers suggest that optimizing the use of registries as well as more rapid clinical trial start up, pre-certified raters and use of a single review board can help accelerate clinical trial execution and development.
For additional information about Cleveland Clinic Lou Ruvo Center for Brain Health, visit ClevelandClinic.org/BrainHealth. For additional information about Cleveland Clinic Center for Neurological Restoration, visit ClevelandClinic.org/Departments/Neurological/Depts/Neurological-Restoration.
June 28 White Coat Ceremony Welcomes New Residents, Fellows
60 Percent of Graduating Class to Remain in Las Vegas
On June 28, 2018, Valley Hospital welcomed a new class of 24 medical residents and four Fellows with a traditional White Coat Ceremony. The White Coat Ceremony is considered a rite of passage in the journey toward becoming a physician. It marks the medical student’s transition from the study of preclinical health sciences to clinical service. As part of the Ceremony, short white coats of a medical student are discarded and long white coats of a physician are officially presented. The long white coat is the symbol of physician clinical service.
Since 2006, Valley Hospital has offered physician residencies and fellowships for physicians-in-training after they complete medical school, known as graduate medical education. Valley Hospital has watched its physician graduates open or join private practices, work as hospitalists, continue their medical training with the military, or enter fellowships for further specialized training.
Valley Hospital offers residency programs in Family Medicine, Internal Medicine, Neurology and Orthopedic Surgery, along with Fellowships in Gastroenterology and Pulmonary/Critical Care Medicine.
“A residency program not only trains new physicians, but it introduces them to their network of referring physicians and future patients,” said Elaine Glaser, CEO of Valley Hospital. “A 2017 report from the American Association of Medical Colleges showed that 54.5 percent of physicians who completed residency training from 2007 through 2016 are practicing in the state where they completed their residency program.* That’s an important statistic as the local healthcare community works to recruit and retain physicians to meet Southern Nevada’s growing demand for providers.”
Statistics from Valley Hospital’s graduating class include:
Overall, 60 percent of Valley Hospital’s graduating residents and fellows will remain in Las Vegas to work in private practice, as hospitalists, in outpatient clinics, and with local Fellowship opportunities at Valley Hospital (Gastroenterology or Pulmonary/Critical Care) and the University of Nevada, Las Vegas School of Medicine Sports Medicine Fellowship.
Two of four graduating Fellows (50 percent) are entering private practice in Las Vegas with specialties in gastroenterology or pulmonary/critical care.
Nearly 40 percent of the graduating Residents have been accepted into Fellowship Programs.
With its second graduating class, the orthopedic surgery residency maintains its 100 percent Fellowship acceptance rate with graduates being accepted at the University of Pennsylvania Orthopaedic Spine Surgery Fellowship, in Philadelphia, PA and the Orthopaedic Sports Medicine Fellowship, Beacon Orthopaedic Research and Education Foundation, Inc. in Cincinnati, OH.
Other Valley Hospital residents have been accepted to out-of-state fellowship programs in:
Infectious Diseases Fellowship, University of Tennessee College of Medicine, Memphis, TN
Kaiser Permanente Southern California Nephrology Fellowship, Los Angeles, CA
Banner University Medical Center Phoenix Endocrinology & Metabolism Fellowship, Phoenix, AZ
“I’m proud that our program has developed outstanding physicians who have been accepted to well-known fellowships,” said Glaser. “It speaks to the quality of our physician leadership, faculty and program.”
Diane Fearon, Dave Marlon, and Alexandra Silver’s Extensive Experience Counted on to Advance HEALS’ Agenda
Las Vegas HEALS, a nonprofit membership-based healthcare association, announced today that it recently welcomed three new members to its Board of Directors: Diane Fearon, Dave Marlon, and Alexandra Silver.
“These new additions to our Board of Directors are invaluable,” said Doug Geinzer, CEO of Las Vegas HEALS. “They bring decades of experience with excellent reputations in the industry and will help us move forward in achieving our goals to improve the quality of healthcare in southern Nevada.”
Diane Fearon is the vice president for philanthropy and strategic partnerships at Nathan Adelson Hospice, the largest nonprofit hospice in southern Nevada, caring for an average of 450 hospice and palliative care patients daily. Prior to her joining the senior leadership team, she served as the Admissions and Transitions Optimization Program (ATOP) director at HealthInsight Nevada. ATOP is a four-year, $17 million grant funded by Centers for Medicare & Medicaid Services (CMS).
David Marlon currently serves as the American Addiction Center (AAC)’s regional vice president of Nevada, overseeing all treatment operations in the state, including Solutions Recovery and the Desert Hope Treatment Facility. Prior to joining AAC, Marlon was the president and co-founder of Solutions Recovery, Inc., an alcohol and drug treatment center that is accredited by the Joint Commission. Since 2005, he has delivered treatment to hundreds of people struggling with chemical dependency and mental illness.
Alexandra Silver currently serves as executive director for Clark County Medical Society. With more than 20 years in operations, program management, and event planning in the nonprofit and private sector as well as numerous years of nonprofit leadership experience, Silver has brought success to the long-standing organization with her remarkable guidance. The Clark County Medical Society advocates for physicians and their patients in southern Nevada, encouraging the delivery of quality healthcare within the community.
Las Vegas HEALS offers several networking opportunities for members to meet other healthcare professionals and businesses that support healthcare. The monthly Healthcare Happy Hour is the largest networking event attended by physicians, healthcare administrators, allied health professionals and those who support the growth of healthcare. The organization recently relocated its offices to the Roseman University Summerlin Campus at One Breakthrough Way. The new space is situated across from Roseman University’s 98-seat auditorium, which the organization will be able to use. The future plans include bringing healthcare industry leaders together for a speaker series on various significant topics affecting this industry on a local level.
Las Vegas HEALS announced the addition of David Marlon to its Board of Directors. Founded in 2002, Las Vegas HEALS (Health, Education, Advocacy, and Leadership in Southern Nevada) is a nonprofit, membership-based association whose mission is to foster strategic alliances in the healthcare community, collaborating on workforce issues, and being a proactive force for legislative initiatives to improve access and the delivery of quality healthcare.
NIPM became a biomedical center of excellence this past week, with an $11.4 million award from the National Institutes of Health. The award represents the first COBRE (center of biomedical research excellence) program led by UNLV. NIPM will leverage the award to foster research efforts at UNLV and across Nevada.
The NIPM COBRE is the first in the nation to focus exclusively on personalized medicine as well as the first Nevada personalized medicine initiative peer-reviewed by a national committee. The award represents the culmination of efforts put forth by a dedicated and hardworking team of staff and faculty at NIPM as well as at collaborating organizations, fueled by seed funding from the Governor’s Office of Economic Development and UNLV. More than 45 experts participated in the application process, and the submission had more than 60 letters of support from recognized organizations or experts in the field. Key local collaborators include UNLV’s National Supercomputing Institute and the Lou Ruvo Center for Brain Health.
Personalized medicine is based on the concept that a person’s unique DNA can guide effective treatment and disease prevention. The main goals of the COBRE grant are to advance the use of genomics and genetics in personalized medicine through cutting-edge research discovery, to build a center of excellence that fosters new investigator independence, and to collaborate with key strategic partners. The program will also build upon computational and genomics research capacity, including expert analysts to enable population-level genomics research. Projects forthcoming through the COBRE include developing new methods for comprehensive tissue-of-origin profiling for cancers of unknown sources; diagnosing osteoporosis based on individual genetic makeup and environment; and examining the role of microglia and immune system dysfunction in schizophrenia to help identify new genetic markers of the condition. The COBRE will also be leveraged to expand clinical and educational services.
Las Vegas native, Bonanza High School and UNLV graduate, Colby Shreve, 29, is now a first-year student at the UNLV School of Medicine. Chosen from a field of more than 800 students for the inaugural class, Shreve’s non-traditional path to medicine included a six-year stint as a professional baseball player after being drafted by the Philadelphia Phillies in 2008 from the College of Southern Nevada.
Mobile Urgent Care Service Now Treating Patients in Southern Nevada
DispathHealth is a new and innovative provider of on-demand mobile urgent care services in Las Vegas, Nevada. Unlike traditional urgent care or emergency room visits, their medical team brings treatment right to the privacy and comfort of a person’s home, work place or senior living community.
This service is convenient, affordable and personal and can be easily requested by phone at 702-848-4443, or through its website or via a free mobile app. Once a request has been triaged and validated as appropriate, patients will be given an estimated time of arrival. The DispatchHealth medical team is then dispatched to the person’s home and will arrive in approximately 60 – 90 minutes.
The medical team consists of an emergency medical technician (EMT) and an ED-trained and board-certified nurse practitioner (NP) or physician assistant (PA) with continual virtual support from an emergency room physician. DispatchHealth’s skilled and experienced providers arrive with the tools necessary to provide advanced medical care and are supported by modern technological infrastructure to ensure quality outcomes.
The DispatchHealth medical team will arrive on scene with the tools and equipment required to treat a wide variety of injuries and illnesses, including the flu, upper respiratory conditions, dehydration, urinary tract infections, nebulizer treatment for COPD, bronchitis, sinus infections, strep throat, sewing up a laceration or skin tear, packing a nose bleed, treating nausea, vomiting, diarrhea, constipation, removing foreign objects (from ears and nose), pink eye, stabilizing a sprained ankle, doing basic blood work on-site, treating headaches/migraines, administering IV fluids, medications, antibiotics and much more.
The concept for DispatchHealth was created in 2013 by an Emergency Room doctor in Denver, Colorado in an attempt to reduce the number of persons utilizing the Emergency Room for non-life threatening health issues that could be treated outside of the hospital setting.
“Our care model has proven acute care can be delivered safely in the convenience of the patient’s home or location of need,” stated DispatchHealth Co-Founder and CEO Mark Prather, MD, MBA. “Whether caring for an elderly parent, an injured or ill child, or facing an acute illness or injury themselves, consumers have a new option to address on-demand healthcare needs without the expense, inconvenience and time so often associated with urgent and emergency care facilities.”
DispatchHealth’s unique, care delivery model and clinical capabilities allows them to treat the entire family from young children to teens, adults and seniors. For busy parents with kids, working adults with hectic schedules to seniors in senior living communities, the services offer a convenient and affordable option – in essence, bringing back the house call.
DispatchHealth has contracted with major health care insurance providers in Las Vegas (including Medicare and Medicaid). After a treatment is completed, DispatchHealth will bill insurance directly. There may be a co-pay (urgent care) required depending on insurance. The co-pay would be collected after DispatchHealth has been paid by the insurance company. The service has an affordable self-pay rate for those individuals without health care coverage, are out of network coverage or have a high deductible plan. Health savings plans are also accepted for payment of services.
DispatchHealth focuses much of their attention on serving the senior community – as they often have fewer options and more difficulties accessing urgent care. They may also have limited transportation options and mobility challenges making it difficult to leave home. Having an option besides calling 911 is critical. Going to the emergency room for non-life threatening situations is not only costly, but can be very disruptive and disorienting. DispatchHealth believes their mobile urgent care solution is taking tremendous steps towards higher quality healthcare delivery, lowering costs and increasing patient satisfaction.
WHAT SETS DISPATCHHEALTH APART
The option of having affordable, personalized care in the home setting is a welcome and much needed addition to the care continuum. Individuals tend to be more relaxed, share more information about their health issues and have better outcomes when treated in their home.
Other advantages include not being exposed to others with serious health issues in an urgent or emergency waiting room setting; having the DispatchHealth medical team able to administer a first dose of medication, as well as write orders for prescriptions during the home visit; and having a medical team completely focused on the patient’s health needs. The average home visit is 45 minutes.
DispatchHealth’s goal is not to replace primary care physicians or home health provider, but support their efforts, when needed, for specific urgent care needs of patients. The medical team leaves a copy of all treatment notes, tests results and prescriptions with the person being treated, and sends a copy to designated primary care physicians and other care providers as requested. DispatchHealth’s objective is to tuck everyone back with their care team when treatment is completed.
DISPATCHHEALTH LOCATIONS & NATIONAL EXPANSION
The original location and corporate office for DispatchHealth is located in Denver, Colorado. Besides Denver, the company has expanded to provide services in Colorado Springs, Colorado, Richmond, Virginia and Phoenix, Arizona.
DispatchHealth started helping patients in Las Vegas on December 1, 2017.
DispatchHealth’s most recent opening, as of two week ago, is Houston, TX. Future expansion includes opening in both Oklahoma City, Oklahoma and Dallas, Texas by early summer. Additional metropolitan locations are under consideration.
DISPATCHHEALTH BUSINESS PHILOSOPHY
The DispatchHealth business motto is “The Right Care at the Right Time at the Right Place.” They believe righteous healthcare can be achieved through the power of technology, convenience and service. Their team works hard to create an integrated delivery solution that extends yet supports the capabilities of a person’s care team, and provides quality care to each individual seen while dramatically decreasing costs for both the consumer and the healthcare industry.
To request care in the Las Vegas Valley: call 702-848-4443.
DISPATCHHEALTH‘S LAS VEGAS TEAM
BJ Wright, Community Engagement Manager
Bill Butcher, Market Director
For those of you who are early adopters like I am, you’re probably aware of the latest Apple technology introduced this month. Apple’s use of consumer data has allowed them to build the best product for consumer needs. They are innovators in their industry. Just like Apple, Regenexx has been on the forefront of the Interventional Orthopedic industry based on our unique ability to track and analyze every one of our patients. We have patients who are 5, 8, 10 or even 12 years out from their nonsurgical Regenexx procedure. This amount of research and data allows us to make advancements in our field that bring patients an outcome based treatment approach customized to their specific orthopedic needs and are grounded in improving the lives of our patients.
Regenexx® stem cell procedures have been studied extensively for more than a decade and our patients are part of the world’s largest human mesenchymal stem cell re-implantation database for orthopedic purposes.
We are the only orthopedic providers in the world with an outcome registry.
Regenexx® Patient Outcome Data by Body Part Treated below:
The current case study shows the economic and physical impact we are making with our corporate clients
As of February, 2018… We have reduced our corporate partners’ orthopedic costs by 84% at an overall savings of nearly $6.140 MILLION dollars with an average patient improvement at 6 months of 80%.
Patient Success is Our Priority
Sheri, a small business owner, was able to keep her company running by avoiding a lengthy recovery and opting for a non-surgical patented Regenexx procedure. Sheri is back to 98 percent of her function and virtually pain free at her six month appointment. See Sheri’s 2-minute video below:
Touro University Nevada will receive more than $21,000 for the Sharon Sigesmund Pierce and Stephen Pierce Center for Autism & Developmental Disabilities from the 10th annual Ante 4 Autism Celebrity Poker Tournament.
The tournament, held inside the Golden Nugget Hotel & Casino, raised more than $137,000 for five autism non-profit organizations across the country. Touro’s Center for Autism & Developmental Disabilities was the lone recipient from Nevada.
“The Ante 4 Autism Celebrity Poker Tournament was a resounding success for the autism community,” said Shelley Berkley, CEO & Senior Provost of Touro University Western Division. “We are so thrilled that our Center for Autism & Developmental Disabilities was a part of this wonderful event. This donation will make a huge impact on our Center.”
The tournament featured several professional poker players, including Erik Seidel, Jennifer Harmon, and tournament co-hosts Chip and Karina Jett among others. Additional celebrity participants included actors Nicholas Gonzalez from “The Good Doctor,” and Dennis Haskins from “Saved by the Bell.”
Ante 4 Autism had nearly 240 players and more than 40 sponsors for the special event.